730. Stable Production of Lentiviral Vectors by the Constitutive RD-MolPack Packaging Technology for Efficient Human Hematopoietic and Primary T Lymphocytes Genetic Modification

Molecular Therapy - United States

doi 10.1016/s1525-0016(16)35743-4